Search results for "lactosa"

showing 10 items of 31 documents

GALACTOSE-DECORATED POLYMERIC CARRIERS FOR HEPATOCYTE-SELECTIVE DRUG TARGETING

2015

In this paper, the current available strategies to realize galactose-decorated nanostructured polymeric systems are summarized. These carriers are designed in order to obtain targeted drug delivery to hepatocytes via galactose (GAL) moieties, i.e., for the treatment of viral hepatitis or liver cancer that are the greater causes of global disability and mortality. Usually, the main followed strategy to obtain galactosylated polymeric carriers is to use galactosylated copolymers. The chemical modifications of preformed polymers with sugar-containing reagents is followed for obtaining lactosaminated human albumin, galactosylated phospholipid-polyaminoacid and polylactide (PLA)- polyaminoacid c…

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoAsialoglycoprotein receptor (ASGP-R) carboxymethyl chitosan (CMC) galactose (GAL) hepatocytes lactosaminated albumin liver targeting poly(ε-caprolactone) (PCL) polyamidoamine (PAMAM) dendrimers polycarbonates polylactide (PLA) xyloglucan αβ-poly(N-2-hydroxyethyl)-DLaspartamide (PHEA).
researchProduct

Synthesis of sialyl-Tn antigen. Regioselective sialylation of a galactosamine threonine conjugate unblocked in the carbohydrate portion

1994

Abstract Regioselective and stereocontrolled formation of the sialyl-Tn antigen conjugate 6 was achieved by reacting the NeuNAc-2-xanthate 2 with the GalNAc threonine acceptor 5 bearing three hydroxy groups. Complete deprotection afforded the sialyl-Tn antigen structure 11 .

Sialyl Tn antigenStereochemistryOrganic ChemistryRegioselectivityCarbohydrateBiochemistrycarbohydrates (lipids)chemistry.chemical_compoundBiochemistrychemistryAntigenGalactosamineDrug DiscoveryThreonineConjugateTetrahedron Letters
researchProduct

Apical transport of osteopontin is independent of N-glycosylation and sialylation.

2002

Studies of how epithelial surface polarity into apical and basolateral domains is generated and maintained have proposed that carbohydrate modifications serve as apical targeting signals for proteins by interacting with lectin sorters. However, the experimental evidence in support of N-glycans, O-glycans and sialic acids mediating apical transport is still very controversial. This could be partly due to the fact that in most studies exogenously expressed proteins were analysed. One has, therefore, examined the role of carbohydrate moieties in apical targeting of the endogenous secretory protein osteopontin in MDCK cells. It was found, however, that sorting of osteopontin does not require N-…

Signal peptideAcetylgalactosamineGlycosylationProtein ConformationSialoglycoproteinsOligosaccharidesBiologyProtein Sorting SignalsKidneyCell Linechemistry.chemical_compoundDogsN-linked glycosylationLectinsCell polarityBenzyl CompoundsAnimalsOsteopontinMolecular BiologyCell PolarityEpithelial CellsCell BiologySialic acidTransport proteincarbohydrates (lipids)Molecular WeightProtein TransportProtein Sorting SignalsSecretory proteinchemistryBiochemistrybiology.proteinSialic AcidsOsteopontinMolecular membrane biology
researchProduct

Inhibition of giant cell formation by compound 48/80 after infection with herpesvirus hominis

1974

Choline kinase has been found to be a soluble enzyme with a molecular weight of 105,000 in the cytoplasm of primary rabbit kidney cells. It has been purified 150-fold. It was investigated whether the inhibiting effect of Cpd 48/80 on virus-induced giant cell formation is due to interference with this enzyme. Cpd 48/80-dimer was shown to inhibit the choline kinase activityin vitro without a concomitant inhibition of giant cell formation. Likewise, another competitive inhibitor of choline kinase, purinyl-6-histamine, does not prevent giant cell formation. This finding suggests that there is no correlation between choline kinase activity and giant cell formation.

Time FactorsCholine kinaseeducationGalactosamineOleic AcidsBiologyKidneyTritiumCholinechemistry.chemical_compoundCytopathogenic Effect ViralBiosynthesisVirologyAnimalsSimplexvirusp-Methoxy-N-methylphenethylamineCarbon RadioisotopesCells Culturedchemistry.chemical_classificationGlucosamineBinding SitesPhosphotransferasesGeneral MedicineCompound 48/80LipidsVirologyMolecular biologyIn vitroEnzymechemistryEthanolaminesCytoplasmGiant cellDepression ChemicalPhosphatidylcholinesTritiumChromatography Thin LayerRabbitsArchiv f�r die gesamte Virusforschung
researchProduct

Synthetic Tumor-Associated Glycopeptide Antigens from the Tandem Repeat Sequence of the Epithelial Mucin MUC4

2004

In cancer research, the development of vaccines against tumor-associated antigens is of particular interest. Epithelial cells express mucin type glycoproteins, which are extensively O-glycosylated. In case of cancer, the expression of these mucins is increased, and their carbohydrate side chains show an aberrant glycosylation pattern. A set of single and double glycosylated hexadecapeptides representing the tandem repeat sequence of the epithelial mucin MUC4 carrying different tumor-associated carbohydrate antigens was prepared by sequential solid-phase glycopeptide synthesis. The crucial glycosyl amino acid building blocks containing the T N , T, sialyl-T N and (2,6)-sialyl-T antigens were…

chemistry.chemical_classificationOrganic ChemistryMucinGeneral MedicineMolecular biologyCatalysisGlycopeptideAmino acidcarbohydrates (lipids)chemistry.chemical_compoundSolid-phase synthesisAntigenchemistryBiochemistryGalactosamineGlycosylThreonineGlycoproteinSynthesis
researchProduct

Synthesis of fluorinated Thomsen-Friedenreich antigens: direct deoxyfluorination of αGalNAc-threonine tert-butyl esters.

2011

Selectively 6-fluorinated analogs of the tumor-associated T(N) antigen Fmoc-Thr(α-O-GalNAc)-OtBu can be efficiently prepared using DAST-mediated de(hydr)oxyfluorination reactions of preformed and orthogonally protected glycosyl amino esters without affecting the labile protecting groups and O-glycosidic linkages. The resulting mono- and difluorinated T(N) analogs are interesting building blocks for non-hydrolyzable mucin-type antigen mimetics, as illustrated by the unprecedented synthesis of two different multiply fluorinated Thomsen-Friedenreich derivatives. The reported deoxyfluoro antigen analogs represent important functional probes for carbohydrate-binding proteins and glycosyl-process…

chemistry.chemical_classificationTert butylThreonineAcetylgalactosamineAmino estersCarbohydrate chemistryStereochemistryOrganic ChemistryFluorineBiochemistrychemistry.chemical_compoundEnzymechemistryAntigenGlycosylAntigens Tumor-Associated CarbohydratePhysical and Theoretical ChemistryThreonineFluorescent DyesOrganicbiomolecular chemistry
researchProduct

Synthetic Glycopeptides of the Tandem Repeat Sequence of the Epithelial Mucin MUC4 with Tumour-associated Carbohydrate Antigens

2004

Glycohexadecapeptides representing the tandem repeat sequence of the epithelial mucin MUC4 were prepared by applying a solid-phase methodology. The required glycosyl amino acid building blocks containing the tumour-associated saccharide antigens T N -, T,- sialyl-T N , (2,6)- and (2,3)-sialyl-T were synthesized according to a straightforward biomimetic strategy by stepwise extension of the saccharide side chain of a Fmoc-protected galactosamine threonine tert-butyl ester.

chemistry.chemical_classificationTumor-Associated Carbohydrate AntigensChemistryOrganic ChemistryMucinGeneral MedicineMolecular biologyGlycopeptideAmino acidcarbohydrates (lipids)chemistry.chemical_compoundAntigenBiochemistryGalactosamineTandem Repeat SequenceSide chainGlycosylThreonineSynlett
researchProduct

Regioselective Glycosylation of Glucosamine and Galactosamine Derivates Using O-Pivaloyl Galactosyl Donors

2003

Penta-O-pivaloyl-galactopyranose and tetra-O-pivaloyl-galactopyranosyl bromide after electrophilic activation reacted with 6-O-protected 2-azido-galactosides to give the precursor structures of the Thomsen-Friedenreich antigen disaccharide with high regioselectivity, but low yield.With 4,6-Obenzylidene protected 2-azidogalactosides and 2-O-pivaloyl phenylthio galactosides, T-antigen disaccharides of this type were obtained in good yields. Glycosylation reactions of 4,6-O-benzylidene protected glucosamine derivatives with O-pivaloyl protected galactosyl bromide efficiently gave lactolactosamine disaccharides. Even a thioglycoside was efficiently galactosylated by this method resulting in the…

chemistry.chemical_compoundGlycosylationchemistryGlucosamineGalactosamineOrganic chemistryRegioselectivityGeneral ChemistryZeitschrift für Naturforschung B
researchProduct

Parasitosis intestinales en pacientes con malabsorción a lactosa y/o fructosa. Valoración del efecto de la terapia combinada

2019

La malabsorción de carbohidratos entre adultos es cada vez más frecuente. Estudios recientes sugieren una relación entre las parasitosis intestinales y el desarrollo de estos procesos patológicos. Las enteroparasitosis provocan cambios en la mucosa intestinal asociados con mala digestión y malabsorción de los alimentos. Este estudio ha analizado la frecuencia de parásitos intestinales en individuos adultos con trastornos gastrointestinales crónicos y diagnóstico de malabsorción a carbohidratos mediante el test de aliento. Para el diagnostico parasitológico se combinaron técnicas convencionales con moleculares. Los parásitos detectados fueron: Giardia intestinalis (24,4%), Blastocystis sp. (…

malabsorciónfructosadieta:CIENCIAS MÉDICAS ::Patología::Parasitología [UNESCO]antiparasitarioUNESCO::CIENCIAS MÉDICAS ::Patología::ParasitologíablastocystisUNESCO::CIENCIAS MÉDICAS ::Ciencias de la Nutriciónlactosaparásitosgiardia:CIENCIAS MÉDICAS ::Ciencias de la Nutrición [UNESCO]
researchProduct

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges

2020

AbstractHemophilia A (HA) and B (HB) are X-linked bleeding disorders caused by mutations in the F8 or F9 gene that result in the absence, or reduced activity, of the corresponding clotting factor. The severity of bleeding and related complications is proportional to the amount of residual circulating functional factor. The development of a safe and effective hemophilia treatment lasted several decades and has been mainly based on clotting factor replacement. Advances in the engineering and manufacturing of clotting concentrates have led to the widespread availability of extended half-life products that reduced the number of intravenous infusions needed to achieve adequate trough levels. The…

medicine.medical_specialtyAcetylgalactosamineInjections SubcutaneousLipoproteinsHemorrhage030204 cardiovascular system & hematologyAntibodies Monoclonal HumanizedHemophilia AHemophilia BSeverity of Illness IndexDisease courseFactor IX03 medical and health sciencesRoute of administrationLife Expectancy0302 clinical medicineAntibodies BispecificmedicineHumansRNA Small InterferingInfusions IntravenousIntensive care medicineFactor IXClotting factorClinical Trials as TopicFactor VIIICoagulantsbusiness.industryGenetic TherapyHematologyIntravenous InfusionsHistory 20th CenturyBlood Coagulation FactorsLaboratoriesbusiness030215 immunologymedicine.drugHämostaseologie
researchProduct